LB-100

LB-100

Catalog Number:
L002370675APE
Mfr. No.:
APE-B4846
Price:
$268
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          LB-100 is an inhibitor of protein phosphatase 2A (PP2A) with anticancer activity, with IC50 of 0.85 μM and 3.87 μM in BxPc-3 and Panc-1 cells, respectively[1].
          In BxPc-3, Panc-1, and SW1990 cells, LB-100 treatment reduced PP2A activity by 30-50%. LB-100 increases the intracellular doxorubicin concentration (about 2.5 times that of the control group) and makes tumor cells more sensitive to the cytotoxicity of doxorubicin[1].
          In a PANC-1 mouse xenograft model, LB-100 (2 mg / kg, intraperitoneal injection) improves the efficacy of the chemotherapy drug doxorubicin. LB-100 increases tumor microvessel density and blood flow velocity on the tumor surface, and decreases tumor volume[1].

      • Properties
        • Alternative Name
          3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid
          CAS Number
          1026680-07-8
          Molecular Formula
          C13H20N2O4
          Molecular Weight
          268.31
          Appearance
          A solid
          Purity
          98.00%
          Solubility
          ≥26.8 mg/mL in H2O; insoluble in EtOH; insoluble in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Gulisudumu Maitiabula, Feng Tian, et al. " Liver PP2A-Cα protects from parenteral nutrition-associated hepatic steatosis." Cell Mol Gastroenterol Hepatol. 2022 May 26;S2352-345X(22)00090-X. PMID: 35643235

    We Also Recommend

    CAY10603

    $292

    YL-109

    $228

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.